Meredith Fisher

Meredith Fisher

Founder at
Violet Therapeutics
Health Technology
Finance
Consumer Services

Profile

Meredith Fisher is the founder of Violet Therapeutics, Inc. (founded in 2022) where she holds the title of Co-founding CEO & Director.
She is currently working as a Director at Nocion Therapeutics, Inc., Firecyte Therapeutics, Inc., and Takeda Digital Ventures.
Additionally, she is a Partner at Mass General Brigham Ventures LLC since 2016.
Previously, she served as the Chief Executive Officer & Director at Mediar Therapeutics, Inc. from 2019 to 2023.
She also worked as a Director & Private Investments at Bracebridge Capital LLC from 2013 to 2015 and as a Senior Director-Technology & Business Development at Enlight Biosciences LLC from 2011 to 2012.
Prior to that, she held the position of Principal at Anadys Pharmaceuticals, Inc. and Idenix Pharmaceuticals LLC.
Dr. Fisher holds a doctorate degree from Harvard University, an undergraduate degree from Mount Holyoke College, and an MBA from the Massachusetts Institute of Technology.

Meredith Fisher active positions

CompaniesPositionStart
Private Equity Investor 2015-12-31
Director/Board Member -
Director/Board Member -
Founder 2021-12-31
Director/Board Member -

Former positions of Meredith Fisher

CompaniesPositionEnd
Chief Executive Officer -
Private Equity Investor 2015-12-30
Chief Tech/Sci/R&D Officer 2012-12-30
IDENIX PHARMACEUTICALS INC Corporate Officer/Principal 2002-12-30
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Meredith Fisher's experience

Training of Meredith Fisher

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Finance

Consumer Services

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Services

  1. Stock Market
  2. Insiders
  3. Meredith Fisher